DENV-specific CD4+ T cells expressing at least IL-2 were also detected following the administration of a booster dose of 1 μg + AS01E or 4 μg + Alum in the subset of initially dengue-naive participants, showing an increase for all four DENV serotypes at day 28 (Supplementary Fig. 5). Here, IL2 is linked to dengue disease.